课题基金 / 基金详情

The Study of Progressive Factors to Developing Glomerular Injury

The Study of Progressive Factors to Developing Glomerular Injury
肾小球损伤进展因素的研究
批准号:
12470210
负责人:
DOI Toshio
金额:
$9.02万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

DOI Toshio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mesangial cell proliferation is a general characteristic of a variety of glomerular injuries. Growth arrest gene 6 (Gas 6) was one of vitamin K-dependent proteins, which was reported that the γ-carboxylation of Gas 6 is essential for its receptor-binding and growth-promoting activities in cells. The present study shows the role of Gas 6 for development of glomerular injury. Gas 6 is a new autocrine growth factor of mesangial cells. We examined the role of Gas 6/Axl in vivo in an experimental anti-Thy1 glomerulonephritis. The expression of Gas 6 was markedly increased in glomeruli in the model and the administration of warfarin significantly inhibited mesangial proliferation and the increased Gas 6 expression. The administration of Axl-extracellular domain (receptor for Gas 6) also inhibited mesangial cell proliferation. Gas 6 induced mesangial cell proliferation via latent transcription factor STAT3 in vitro and in vivo. To investigate these findings, we constructed Gas 6-/- mice and examined the role of it in accelerated nephrotoxic nephritis. Gas 6-/- mice showed less proteinuria, glomerular cell proliferation, glomerulosvlerosis and crescent formation than wild-type nephritis. These data indicate that Gas 6 contributes to glomerular injury and the progression of glomerular sclerosis.
期刊论文(42)
专著(0)
科研奖励(0)
会议论文
M.Yanagita: "Essential role of Gas6 for glomerular injury in nephrotoxic nephritis"J Clin Invest.. 110(2). 239-246 (2002)
M.Yanagita:“Gas6 对肾毒性肾炎肾小球损伤的重要作用”J Clin Invest.. 110(2)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Imabayashi: "Expression of basic helix-loop-helix proteins in the glomeruli"Clinical Nephrology. 55. 53-58 (2001)
T.Imabayashi:“肾小球中碱性螺旋-环-螺旋蛋白的表达”临床肾病学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K.Makibayashi: "A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis"American Journal of Pathology. 158(5). 1733-1741 (2001)
K.Makibayashi:“维生素 D 类似物可改善大鼠肾小球肾炎的肾小球损伤”《美国病理学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Yanagita: "Gas6 induces mesangial cell proliferation via latent transcription factor STAT3"The Journal of Biological Chemistry. 276(45). 42364-42369 (2001)
M.Yanagita:“Gas6 通过潜在转录因子 STAT3 诱导系膜细胞增殖”《生物化学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Establishment of non-invasive diagnostic method for CKD by using urinary exosomes.
    • 批准号:
      23659445
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      DOI Toshio
    • 依托单位:
    Development of Specific Biomarker and Molecular Targeting Therapy for Diabetic Nephropathy by RAS-independent Pathway
    • 批准号:
      22390169
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2010
    • 负责人:
      DOI Toshio
    • 依托单位:
    An International Collaborative Study to investigate Genetic Susceptibility for chronic Kidney Disease Which is Common in Asian
    • 批准号:
      15406033
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.58万
    • 财政年份:
      2003
    • 负责人:
      DOI Toshio
    • 依托单位:
    Investigation for progressive factors of glomerulosclerosis.
    国内基金
    海外基金
    BRD4通过结合TEAD1调控β细胞增殖分化的机制研究
    • 批准号:
      82370801
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      李峰
    • 依托单位:
    放疗通过激活GSDMD诱发细胞焦亡促进肿瘤再增殖的机制研究及干预策略探讨
    • 批准号:
      82373299
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      程进
    • 依托单位:
    线粒体呼吸链复合体I对果蝇肠道干细胞增殖分化的调控作用及内在机制
    • 批准号:
      32100586
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      陈菲
    • 依托单位:
    溴结构域蛋白BRD4促进三阴性乳腺癌恶性生物学行为的机制研究
    • 批准号:
      32100584
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      卢琳琳
    • 依托单位: